KO · Healthcare

Sk Biopharmaceuticals Co Ltd (326030)

Biotechnology

Sk Biopharmaceuticals Co Ltd (326030) is listed on KO in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 326030

P/E ratio

25.00

Sk Biopharmaceuticals Co Ltd (326030) — FAQ

What is 326030's P/E ratio?

The price-to-earnings (P/E) ratio for Sk Biopharmaceuticals Co Ltd (326030) is 25.00 (data as of 2026-05-24).

Does Sk Biopharmaceuticals Co Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Sk Biopharmaceuticals Co Ltd (326030). Check the MyAverix Finance app for the latest dividend data.

What sector is Sk Biopharmaceuticals Co Ltd in?

Sk Biopharmaceuticals Co Ltd (326030) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 326030 listed on?

326030 is listed on KO.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)